Integration of peripheral blood lymphocyte subsets and cytokines enhances prognostic stratification in newly diagnosed multiple myeloma
British Journal of Haematology · 04.11.2026
DOI: 10.1111/bjh.70932 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Haematology, online erschienen am 04.11.2026. Verfasst von Xianghong Zhao und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Tianjin Medical University General Hospital, Tianjin, China. Die Arbeit nennt 44 Literaturangaben. Gefördert von: the Key research and development projects of the Ministry of Science and Technology, the National Natural Science Foundation of China, the Tianjin Municipal Natural Science Foundation.
Abstract (Originalsprache)
Immune dysregulation is involved in multiple myeloma (MM) pathogenesis and progression yet current staging systems do not incorporate indicators of immune status. We retrospectively included 260 newly diagnosed multiple myeloma (NDMM) patients with baseline data of peripheral blood (PB) lymphocyte subsets and cytokines from Tianjin Medical University General Hospital. Through majority voting across seven survival prediction algorithms and subsequent Cox analysis, cluster of differentiation (CD)3 + CD8 + T‐cell absolute count and interleukin (IL‐10) were identified as immune prognostic predictors to construct the immune risk score. A comprehensive prognostic nomogram was subsequently established by combining this score with high‐risk cytogenetic abnormalities, serum calcium and serum lactate dehydrogenase. Shapley additive explanation analysis ranked the immune risk score as the leading contributor to the final model. The nomogram achieved a cross‐validated 3‐year time‐dependent area under the curve for overall survival (OS) of 0.825. The model was further evaluated in a temporal validation cohort. In exploratory analyses within our cohort, the nomogram showed better prognostic performance than the established staging systems and further stratified outcomes among patients receiving anti‐CD38 antibody‐containing regimens. The model was deployed as an exploratory online calculator for convenience. These findings require independent external multicentre validation before implementation.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Hematology, Tianjin Medical University General Hospital, Tianjin, China.
- Tianjin Key Laboratory of Bone Marrow Failure and Malignant Hemopoietic Clone Control, Tianjin, China.
- Tianjin Institute of Hematology, Tianjin, China.
ORCID-Profile: Zhaoyun Liu, Hui Liu, Jia Song, Rong Fu
Förderung
- the Key research and development projects of the Ministry of Science and Technology
- the National Natural Science Foundation of China
- the Tianjin Municipal Natural Science Foundation
- the Tianjin Science and Technology Planning Project
- Tianjin Municipal Health Commission Project
- State Key Laboratory of Experimental Hematology
- Tianjin Key Medical Discipline Construction Project
Zitieren
APA
Zhao, X., Liu, Z., Qin, G., Wang, J., Liu, H., Ding, K., Song, J., & Fu, R. (2026). Integration of peripheral blood lymphocyte subsets and cytokines enhances prognostic stratification in newly diagnosed multiple myeloma. British Journal of Haematology. https://doi.org/10.1111/bjh.70932
Vancouver
Zhao X, Liu Z, Qin G, Wang J, Liu H, Ding K, et al. Integration of peripheral blood lymphocyte subsets and cytokines enhances prognostic stratification in newly diagnosed multiple myeloma. British Journal of Haematology. 2026. doi:10.1111/bjh.70932
BibTeX
@article{Zhao2026,
author = {Zhao, Xianghong and Liu, Zhaoyun and Qin, Gong and Wang, Junzhu and Liu, Hui and Ding, Kai and Song, Jia and Fu, Rong},
title = {Integration of peripheral blood lymphocyte subsets and cytokines enhances prognostic stratification in newly diagnosed multiple myeloma},
journal = {British Journal of Haematology},
year = {2026},
doi = {10.1111/bjh.70932}
}
EUVIMED